Neovii Pharmaceuticals AG

Neovii is an independent, global biopharmaceutical company with a patient-focused mission to develop and bring to market novel life-transforming therapies to improve the outcomes in transplantation medicine, hemato-oncological and immune disorders. Neovii was founded following the acquisition of Fresenius Biotech inheriting more than three decades of experience in specialty pharmaceuticals. We welcome new business partnerships and product opportunities for development, distribution, in-licensing or acquisition that can help us achieve our mission of bringing life-transforming therapies to treat patients with unmet medical need around the world.